|
RDH14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.694400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.211400E-01 |
| Normal-vs-Stage2 |
9.914000E-01 |
| Normal-vs-Stage3 |
2.792200E-01 |
| Normal-vs-Stage4 |
1.553440E-01 |
| Stage1-vs-Stage2 |
5.525400E-01 |
| Stage1-vs-Stage3 |
3.046100E-02 |
| Stage1-vs-Stage4 |
1.138250E-02 |
| Stage2-vs-Stage3 |
5.373000E-01 |
| Stage2-vs-Stage4 |
4.152400E-01 |
| Stage3-vs-Stage4 |
7.530400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.562400E-01 |
| Normal-vs-AfricanAmerican |
6.652200E-01 |
| Normal-vs-Asian |
3.212200E-01 |
| Caucasian-vs-AfricanAmerican |
6.668800E-01 |
| Caucasian-vs-Asian |
5.525000E-01 |
| AfricanAmerican-vs-Asian |
3.721000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.038200E-02 |
| Normal-vs-Female |
7.939800E-03 |
| Male-vs-Female |
2.76769999996151E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.810400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.355600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.056800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.319400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.851600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.681830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.002400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.138600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.964400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.646600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.502400E-01 |
| Normal-vs-Grade 2 |
5.169500E-02 |
| Normal-vs-Grade 3 |
2.465400E-01 |
| Normal-vs-Grade 4 |
9.676900E-03 |
| Grade 1-vs-Grade 2 |
7.876400E-01 |
| Grade 1-vs-Grade 3 |
1.259360E-01 |
| Grade 1-vs-Grade 4 |
1.915840E-02 |
| Grade 2-vs-Grade 3 |
1.563010E-03 |
| Grade 2-vs-Grade 4 |
4.2599000000032E-05 |
| Grade 3-vs-Grade 4 |
7.540000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.209100E-04 |
| Normal-vs-ccB subtype |
1.597090E-03 |
| ccA subtype-vs-ccB subtype |
2.40270026097278E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.678200E-01 |
| Normal-vs-N1 |
1.186210E-01 |
| N0-vs-N1 |
2.440400E-01 |
|
|
